Qualigen Therapeutics Inc (QLGN) stock is down 5.13% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With QLGN Stock Today?
Qualigen Therapeutics Inc (QLGN) stock is lower by -9.14% while the S&P 500 is higher by 0.13% as of 11:18 AM on Wednesday, Dec 16. QLGN is lower by -$0.37 from the previous closing price of $4.07 on volume of 1,874,275 shares. Over the past year the S&P 500 is up 15.92% while QLGN is lower by -8.64%. QLGN lost -$4.68 per share in the over the last 12 months.
To see the top 5 stocks in the Biotechnology industry click here.
More About Qualigen Therapeutics Inc
Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.
Click Here to get the full Stock Score Report on Qualigen Therapeutics Inc (QLGN) Stock.
